Suerie Moon
Directeur/Membre du Conseil chez Drugs for Neglected Diseases initiative
Profil
Suerie Moon is currently the Secretary & Director at Drugs for Neglected Diseases initiative and an Instructor-Public Health at Harvard University.
Previously, she worked as the Director at Médecins Sans Frontières USA, Inc. She holds a doctorate degree from Harvard University, an undergraduate degree from Yale University, and a graduate degree from Princeton University.
Postes actifs de Suerie Moon
| Sociétés | Poste | Début |
|---|---|---|
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 22/11/2010 |
Drugs for Neglected Diseases initiative
 Drugs for Neglected Diseases initiative BiotechnologyHealth Technology Drugs for Neglected Diseases initiative provides drug research and development services. It specializes in analyzing the causes of and in developing medicine and treatments for neglected diseases. It specializes in the study of neglected tropical diseases, such as sleeping sickness (Human African Trypanosomiasis), Leishmaniasis, Chagas, malaria, pediatric HIV, and filarial diseases. It develops a research and development portfolio that includes projects from discovery through to post-registration phases. Its focus areas encompass regional disease-specific platform development, technology transfer, and public responsibility and awareness advocacies. The organization was founded in July 2003 and is headquartered in Geneva, Switzerland. | Directeur/Membre du Conseil | - |
Anciens postes connus de Suerie Moon
| Sociétés | Poste | Fin |
|---|---|---|
Médecins Sans Frontières USA, Inc.
 Médecins Sans Frontières USA, Inc. Miscellaneous Commercial ServicesCommercial Services Médecins Sans Frontières USA, Inc. delivers emergency medical assistance. The firm has branch offices operate in Argentina, Czech Republic, India, Ireland, Mexico, South Korea and United Arab Emirates. The company was founded by Pascal Greletty-Bosviel , Gérard Illiouz, Bernard Kouchner, Gérard Pigeon, Vladan Radoman, Max Recamier, Jean-Michel Wild, Jacques Beres, Jacques Beres, Raymond Borel, Jean Cabrol, Marcel Delcourt, Xavier Emmanuelli on December 22, 1971 and is headquartered in New York, NY. | Directeur/Membre du Conseil | - |
Formation de Suerie Moon
| Harvard University | Doctorate Degree |
| Yale University | Undergraduate Degree |
| Princeton University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Médecins Sans Frontières USA, Inc.
Médecins Sans Frontières USA, Inc. Miscellaneous Commercial ServicesCommercial Services Médecins Sans Frontières USA, Inc. delivers emergency medical assistance. The firm has branch offices operate in Argentina, Czech Republic, India, Ireland, Mexico, South Korea and United Arab Emirates. The company was founded by Pascal Greletty-Bosviel , Gérard Illiouz, Bernard Kouchner, Gérard Pigeon, Vladan Radoman, Max Recamier, Jean-Michel Wild, Jacques Beres, Jacques Beres, Raymond Borel, Jean Cabrol, Marcel Delcourt, Xavier Emmanuelli on December 22, 1971 and is headquartered in New York, NY. | Commercial Services |
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative BiotechnologyHealth Technology Drugs for Neglected Diseases initiative provides drug research and development services. It specializes in analyzing the causes of and in developing medicine and treatments for neglected diseases. It specializes in the study of neglected tropical diseases, such as sleeping sickness (Human African Trypanosomiasis), Leishmaniasis, Chagas, malaria, pediatric HIV, and filarial diseases. It develops a research and development portfolio that includes projects from discovery through to post-registration phases. Its focus areas encompass regional disease-specific platform development, technology transfer, and public responsibility and awareness advocacies. The organization was founded in July 2003 and is headquartered in Geneva, Switzerland. | Health Technology |
